BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Qiu B, Zhao MF, Yue ZD, Zhao HW, Wang L, Fan ZH, He FL, Dai S, Yao JN, Liu FQ. Combined transjugular intrahepatic portosystemic shunt and other interventions for hepatocellular carcinoma with portal hypertension. World J Gastroenterol 2015; 21(43): 12439-12447 [PMID: 26604651 DOI: 10.3748/wjg.v21.i43.12439]
URL: https://www.wjgnet.com/1007-9327/full/v21/i43/12439.htm
Number Citing Articles
1
Christine Cannataci, Biagio Cimo’, Giuseppe Mamone, Fabio Tuzzolino, Mario D’Amico, Kelvin Cortis, Luigi Maruzzelli, Roberto Miraglia. Portal vein puncture-related complications during transjugular intrahepatic portosystemic shunt creation: Colapinto needle set vs Rösch-Uchida needle setLa radiologia medica 2021; 126(11): 1487 doi: 10.1007/s11547-021-01404-1
2
Yan Zhang, Da-Feng Mao, Mei-Wu Zhang, Xiao-Xiang Fan. Clinical value of liver and spleen shear wave velocity in predicting the prognosis of patients with portal hypertensionWorld Journal of Gastroenterology 2017; 23(45): 8044-8052 doi: 10.3748/wjg.v23.i45.8044
3
Jiaywei Tsauo, Jun Tie, Hui Xue, Jian-Bo Zhao, Jian-Jun Li, Zhu-Ting Fang, Wu-Hua Guo, Xiao Li. Transjugular Intrahepatic Portosystemic Shunt Creation for the Prevention of Gastric Variceal Rebleeding in Patients with Hepatocellular Carcinoma: A Multicenter Retrospective StudyJournal of Vascular and Interventional Radiology 2021; 32(7): 963 doi: 10.1016/j.jvir.2021.04.005
4
David M. Ruohoniemi, Bedros Taslakian, Eric A. Aaltonen, Ryan Hickey, Amish Patel, Jeremy C. Horn, Matthew Chiarello, Meredith McDermott. Comparative Analysis of Safety and Efficacy of Transarterial Chemoembolization for the Treatment of Hepatocellular Carcinoma in Patients with and without Pre-Existing Transjugular Intrahepatic Portosystemic ShuntsJournal of Vascular and Interventional Radiology 2020; 31(3): 409 doi: 10.1016/j.jvir.2019.11.020
5
Dalia Mitraitė, Paula Zibalytė, Erikas Strupeikis, Sigita Gelman. ULTRAGARSINIO TYRIMO REIKŠMĖ VERTINANT TRANSJUGULINIO INTRAHEPATINIO PORTOSISTEMINIO ŠUNTO (TIPS) PROCEDŪROS VEIKSMINGUMĄ IR KOMPLIKACIJŲ RIZIKĄ PO PROCEDŪROSMedicinos teorija ir praktika 2016; 22(2): 127 doi: 10.15591/mtp.2016.018
6
Jenny Yan, Xiaohan Ying, Anuj Malhotra, Adam Talenfeld, Resmi Charalel, Kyungmouk Steve Lee, David Trost, Andrew Kesselman. Safety and Efficacy of Microwave Ablation for Hepatocellular Carcinoma in the Setting of Transjugular Intrahepatic Portosystemic ShuntCardioVascular and Interventional Radiology 2022; 45(5): 578 doi: 10.1007/s00270-021-03012-y
7
Shi-Hua Luo, Jian-Guo Chu, He Huang, Ke-Chun Yao. Safety and efficacy of transjugular intrahepatic portosystemic shunt combined with palliative treatment in patients with hepatocellular carcinomaWorld Journal of Clinical Cases 2019; 7(13): 1599-1610 doi: 10.12998/wjcc.v7.i13.1599
8
Ketan Y. Shah, Ron C. Gaba. Transjugular Intrahepatic Portosystemic Shunt Creation in Patients with Hepatocellular Carcinoma and Bleeding Gastric Varices: More Data, More QuestionsJournal of Vascular and Interventional Radiology 2021; 32(7): 971 doi: 10.1016/j.jvir.2021.05.011
9
Junyang Luo, Mingan Li, Chun Wu, Duo Zhu, Haofan Wang, Mingsheng Huang, Zaibo Jiang. Transjugular intrahepatic portosystemic shunt versus endoscopic therapy for prevention of variceal rebleeding in patients with hepatocellular carcinoma meeting the Milan criteriaEuropean Journal of Gastroenterology & Hepatology 2021; 33(3): 436 doi: 10.1097/MEG.0000000000001750
10
Hai-lin Lu, Fei-fei Xuan, Yao-chang Luo, Xiao Qin. Efficacy and safety of transjugular intrahepatic portosystemic shunt combined with transcatheter embolization/chemoembolization in hepatocellular carcinoma with portal hypertension and arterioportal shuntAbdominal Radiology 2021; 46(11): 5417 doi: 10.1007/s00261-021-03214-5
11
He Zhao, Jiaywei Tsauo, Xiaowu Zhang, Tao Gong, Jinggui Li, Xiao Li. Transjugular intrahepatic portosystemic shunt creation for portal hypertension in patients with hepatocellular carcinoma: A systematic reviewInternational Journal of Gastrointestinal Intervention 2018; 7(3): 167 doi: 10.18528/gii180026
12
Hae Lim Lee, Sung Won Lee. The role of transjugular intrahepatic portosystemic shunt in patients with portal hypertension: Advantages and pitfallsClinical and Molecular Hepatology 2022; 28(2): 121 doi: 10.3350/cmh.2021.0239
13
J. Tsauo, S.Y. Noh, J.H. Shin, D.I. Gwon, K. Han, J.M. Lee, U.B. Jeon, Y.H. Kim. Retrograde transvenous obliteration for the prevention of variceal rebleeding in patients with hepatocellular carcinoma: a multicentre retrospective studyClinical Radiology 2021; 76(9): 681 doi: 10.1016/j.crad.2021.05.011
14
Bin Qiu, Kai Li, Xiaoqun Dong, Fu-Quan Liu. Transjugular Intrahepatic Portosystemic Shunt for Portal Hypertension in Hepatocellular Carcinoma with Portal Vein Tumor ThrombusCardioVascular and Interventional Radiology 2017; 40(9): 1372 doi: 10.1007/s00270-017-1655-8